Phase II Study of Pegylated Liposomal Doxorubicin in Heavily Pretreated Epithelial Ovarian Cancer Patients (Q57903888)
scientific article published on 01 January 2004
Language:
(P31) (Q13442814)
(P50) (Q38524419)
(Q67919065)
(P304) 243-249
(P407) (Q1860)
(P433) 3-4
(P478) 67
(P577) Thursday, January 1, 2004
(P921) (Q172341)
(Q18936)
(P1433) (Q2016300)
(P1476) "Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?" (language: en)
(P2093) Naldini A
Testa A
D'Agostino G
Scambia G
(P2860) (Q33332312)
(Q57265736)
(Q34462134)
(Q41608005)
(Q27860904)
(Q33333411)
(Q31440187)
(Q47830237)
other details
description scientific article published on 01 January 2004

External Links